Ameriprise
OLMA icon

Ameriprise’s Olema Pharmaceuticals OLMA Stock Holding History

Ameriprise’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Buy
840,646
+783,284
+1,366% +$10.5M ﹤0.01% 2022
2026
Q1 		$855K Sell
57,362
-147,267
-72% -$3.28M ﹤0.01% 3374
2025
Q4 		$5.12M Sell
204,629
-942,439
-82% -$16.8M ﹤0.01% 2416
2025
Q3 		$11.2M Sell
1,147,068
-25,795
-2% -$155K ﹤0.01% 1832
2025
Q2 		$5M Buy
1,172,863
+773,064
+193% +$3.45M ﹤0.01% 2361
2025
Q1 		$1.5M Sell
399,799
-49,899
-11% -$251K ﹤0.01% 3040
2024
Q4 		$2.62M Sell
449,698
-13,426
-3% -$134K ﹤0.01% 2773
2024
Q3 		$5.53M Buy
463,124
+22,058
+5% +$282K ﹤0.01% 2299
2024
Q2 		$4.77M Buy
441,066
+127,820
+41% +$1.39M ﹤0.01% 2350
2024
Q1 		$3.55M Buy
313,246
+52,889
+20% +$682K ﹤0.01% 2574
2023
Q4 		$3.65M Sell
260,357
-88,918
-25% -$1.19M ﹤0.01% 2558
2023
Q3 		$4.31M Buy
349,275
+119,910
+52% +$1.22M ﹤0.01% 2395
2023
Q2 		$2.07M Buy
+229,365
New +$1.38M ﹤0.01% 2850
2021
Q4 		– Sell
-210,926
Closed -$5.82M – 4025
2021
Q3 		$5.82M Sell
210,926
-311,148
-60% -$8.4M ﹤0.01% 2281
2021
Q2 		$14.6M Buy
522,074
+57,060
+12% +$1.62M ﹤0.01% 1602
2021
Q1 		$15.4M Buy
465,014
+98,412
+27% +$4.22M 0.01% 1533
2020
Q4 		$17.6M Buy
+366,602
New +$17.2M 0.01% 1316

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Ameriprise's OLMA Position: Q2 2026 in Review

Ameriprise increased its Olema Pharmaceuticals (OLMA) stake by 1,366% in Q2 2026, buying an estimated $10.5M and bringing the position to 840,646 shares worth $10.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

Ameriprise first reported a position in OLMA in Q4 2020 and has held it in 17 quarters since. The position peaked at $17.6M in Q4 2020. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Ameriprise held 840,646 shares of Olema Pharmaceuticals worth $10.5M as of Q2 2026.
  • Ameriprise bought 783,284 Olema Pharmaceuticals shares in Q2 2026, an estimated $10.5M.
  • Olema Pharmaceuticals made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2022 holding.
  • Ameriprise first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 17 quarters since.
  • Ameriprise's Olema Pharmaceuticals position peaked at $17.6M in Q4 2020.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.